Vuckovic group focuses on the development of new analytical methods for high-throughput clinical and preventative health metabolomics. Her lab primarily focuses on enhancing the analytical performance of mass spectrometry-based methods with a particular emphasis on the development of better extraction and separation technologies for improving the detection of low abundance metabolome and annotation of metabolite biological availability. The group’s major current projects include studies of circadian rhythm, cardiovascular health, stress and mood disorders such bipolar disorder. Her group also develops novel validated targeted mass spectrometric methods for diverse sets of analytes of interest ranging from mycotoxins and drugs to endogenous metabolites such as eicosanoids in biological fluids and tissues.